These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 28431962)

  • 1. Structural basis, chemical driving forces and biological implications of flavones as Cu(II) ionophores.
    Dai F; Yan WJ; Du YT; Bao XZ; Li XZ; Zhou B
    Free Radic Biol Med; 2017 Jul; 108():554-563. PubMed ID: 28431962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Designing salicylaldehyde isonicotinoyl hydrazones as Cu(II) ionophores with tunable chelation and release of copper for hitting redox Achilles heel of cancer cells.
    Ji Y; Dai F; Zhou B
    Free Radic Biol Med; 2018 Dec; 129():215-226. PubMed ID: 30240704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Keto-enol-based modification on piperlongumine to generate a potent Cu(II) ionophore that triggers redox imbalance and death of HepG2 cells.
    Dai F; Yuan CH; Ji Y; Du YT; Bao XZ; Wu LX; Jin XL; Zhou B
    Free Radic Biol Med; 2018 May; 120():124-132. PubMed ID: 29555591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting redox vulnerability of cancer cells by prooxidative intervention of a glutathione-activated Cu(II) pro-ionophore: Hitting three birds with one stone.
    Bao XZ; Dai F; Li XR; Zhou B
    Free Radic Biol Med; 2018 Aug; 124():342-352. PubMed ID: 29935260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The oncology drug elesclomol selectively transports copper to the mitochondria to induce oxidative stress in cancer cells.
    Nagai M; Vo NH; Shin Ogawa L; Chimmanamada D; Inoue T; Chu J; Beaudette-Zlatanova BC; Lu R; Blackman RK; Barsoum J; Koya K; Wada Y
    Free Radic Biol Med; 2012 May; 52(10):2142-50. PubMed ID: 22542443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A hydrogen peroxide-activated Cu(II) pro-ionophore strategy for modifying naphthazarin as a promising anticancer agent with high selectivity for generating ROS in HepG2 cells over in L02 cells.
    Bao XZ; Wang Q; Ren XR; Dai F; Zhou B
    Free Radic Biol Med; 2020 May; 152():597-608. PubMed ID: 31805398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of novel coumarin nucleus-based DPA drug-like molecular entity: In vitro DNA/Cu(II) binding, DNA cleavage and pro-oxidant mechanism for anticancer action.
    Khan S; Malla AM; Zafar A; Naseem I
    PLoS One; 2017; 12(8):e0181783. PubMed ID: 28763458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polyether ionophores-promising bioactive molecules for cancer therapy.
    Huczyński A
    Bioorg Med Chem Lett; 2012 Dec; 22(23):7002-10. PubMed ID: 23063400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cu(II)-coumestrol interaction leads to ROS-mediated DNA damage and cell death: a putative mechanism for anticancer activity.
    Zafar A; Singh S; Naseem I
    J Nutr Biochem; 2016 Jul; 33():15-27. PubMed ID: 27260464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Copper homeostasis: Emerging target for cancer treatment.
    Li Y
    IUBMB Life; 2020 Sep; 72(9):1900-1908. PubMed ID: 32599675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A copper chelate induces apoptosis and overcomes multidrug resistance in T-cell acute lymphoblastic leukemia through redox imbalance and inhibition of EGFR/PI3K/Akt expression.
    Banerjee K; Das S; Sarkar A; Chatterjee M; Biswas J; Choudhuri SK
    Biomed Pharmacother; 2016 Dec; 84():71-92. PubMed ID: 27639544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycosylated copper(II) ionophores as prodrugs for β-glucosidase activation in targeted cancer therapy.
    Oliveri V; Viale M; Caron G; Aiello C; Gangemi R; Vecchio G
    Dalton Trans; 2013 Feb; 42(6):2023-34. PubMed ID: 23174818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New 8-hydroxyquinoline galactosides. The role of the sugar in the antiproliferative activity of copper(II) ionophores.
    Oliveri V; Viale M; Aiello C; Vecchio G
    J Inorg Biochem; 2015 Jan; 142():101-8. PubMed ID: 25450024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Developing Anticancer Copper(II) Pro-drugs Based on the Nature of Cancer Cells and the Human Serum Albumin Carrier IIA Subdomain.
    Gou Y; Qi J; Ajayi JP; Zhang Y; Zhou Z; Wu X; Yang F; Liang H
    Mol Pharm; 2015 Oct; 12(10):3597-609. PubMed ID: 26354410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ternary dinuclear copper(II) complexes of a hydroxybenzamide ligand with diimine coligands: the 5,6-dmp ligand enhances DNA binding and cleavage and induces apoptosis.
    Ramakrishnan S; Shakthipriya D; Suresh E; Periasamy VS; Akbarsha MA; Palaniandavar M
    Inorg Chem; 2011 Jul; 50(14):6458-71. PubMed ID: 21671566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Cu/ligand stoichiometry effect on the coordination behavior of aroyl hydrazone with copper(II): Structure, anticancer activity and anticancer mechanism.
    Deng J; Gou Y; Chen W; Fu X; Deng H
    Bioorg Med Chem; 2016 May; 24(10):2190-8. PubMed ID: 27056799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ATOX1 gene silencing increases susceptibility to anticancer therapy based on copper ionophores or chelating drugs.
    Barresi V; Spampinato G; Musso N; Trovato Salinaro A; Rizzarelli E; Condorelli DF
    J Inorg Biochem; 2016 Mar; 156():145-52. PubMed ID: 26784148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Redox cycling of Cu(II) by 6-mercaptopurine leads to ROS generation and DNA breakage: possible mechanism of anticancer activity.
    Rehman SU; Zubair H; Sarwar T; Husain MA; Ishqi HM; Nehar S; Tabish M
    Tumour Biol; 2015 Feb; 36(2):1237-44. PubMed ID: 25344215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. X-ray and solution structures of Cu(II) GHK and Cu(II) DAHK complexes: influence on their redox properties.
    Hureau C; Eury H; Guillot R; Bijani C; Sayen S; Solari PL; Guillon E; Faller P; Dorlet P
    Chemistry; 2011 Aug; 17(36):10151-60. PubMed ID: 21780203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transition metal chelators, pro-chelators, and ionophores as small molecule cancer chemotherapeutic agents.
    Steinbrueck A; Sedgwick AC; Brewster JT; Yan KC; Shang Y; Knoll DM; Vargas-Zúñiga GI; He XP; Tian H; Sessler JL
    Chem Soc Rev; 2020 Jun; 49(12):3726-3747. PubMed ID: 32525153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.